Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Int J Ophthalmol ; 16(7): 1034-1040, 2023.
Article in English | MEDLINE | ID: mdl-37465502

ABSTRACT

AIM: To evaluate effects of endogenous dopamine induced by low concentration atropine eye drops on choroidal neovascularization (CNV) in high myopia mice. METHODS: The C57BL/6J mice were deprived of the right eye for 4wk, and the high myopia was diagnosed by optometry, the diopter was less than -6.00 D, and CNV was induced by 532 nm laser. The changes of dopamine D1 receptor (DRD1), dopamine D2 receptor (DRD2), and vascular endothelial growth factor A (VEGFA) were detected by Western blot technology at 0.5, 1, 2h, and 7d after 0.01%, 0.05%, and 0.1% atropine eye drops, respectively, the area of CNV was measured. RESULTS: Significant increases were observed on the expression of DRD2 in mouse high myopia model at 0.5, 1, 2h, 7d with 0.05% and 0.1% atropine eye drops (P<0.05). Significant decreases were observed on the expression of DRD1 and VEGFA in mouse high myopia model at 0.5, 1, 2h, 7d with 0.05% and 0.1% atropine eye drops (P<0.05). The area of CNV induced by laser in the drug-treated group was significantly smaller than that in the control group, and the higher the concentration, the more significant the inhibitory effect (P<0.05). CONCLUSION: The 0.01%, 0.05%, 0.1% atropine eye drops can decrease the level of VEGFA and inhibit high myopia CNV indirectly by up-regulating the level of DRD2 and down-regulating the level of DRD1, and the effect of 0.05% and 0.1% atropine eye drops is more significant.

2.
Hepat Mon ; 15(8): e29183, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26322110

ABSTRACT

BACKGROUNDS: Serum hepatitis B surface antigen (HBsAg) levels are associated with fibrosis in patients with chronic hepatitis B (CHB) infection. OBJECTIVES: The aim of our study was to evaluate serum HBsAg level as a biomarker for compensated cirrhosis in hepatitis B e antigen (HBeAg) positive CHB patients. PATIENTS AND METHODS: Two-hundred and one HBeAg-positive Chinese CHB patients with or without cirrhosis were enrolled in this retrospective study. Cirrhosis was diagnosed based on liver biopsy. Furthermore, patients with decompensated cirrhosis were excluded. A statistical analysis was performed regarding the association between serum HBsAg level and compensated cirrhosis. RESULTS: Patients with compensated cirrhosis had a significantly lower mean serum HBsAg level compared to those without cirrhosis (3.27 Log10 IU/mL VS 4.17 Log10 IU/mL, P < 0.001). Furthermore, examining the correlation with compensated cirrhosis revealed that lower level of serum HBsAg was a significant factor in multivariate analysis. The area under the receiver operating characteristics curve of serum HBsAg was 0.856 for compensated cirrhosis. A positive predictive value of 66.2% and negative predictive value of 90.7% were obtained with a cut-off value of < 3.60 Log10 IU/mL (4000 IU/mL) of serum HBsAg. Moreover, the rate of compensated cirrhosis increased to 75.0% after combining with APRI > 2. CONCLUSIONS: In HBeAg positive CHB patients, low serum HBsAg level is a useful predictor of compensated cirrhosis.

3.
World J Gastroenterol ; 21(2): 653-60, 2015 Jan 14.
Article in English | MEDLINE | ID: mdl-25605989

ABSTRACT

AIM: To observe the effect of response-guided add-on therapy with adefovir (ADV) and lamivudine (LAM) in cirrhotic hepatitis B (CHB) patients. METHODS: A total of 100 patients with CHB and cirrhosis were divided into three arms according to hepatitis B virus (HBV) DNA level after 24 wk LAM monotherapy: Arm A (complete response, HBV DNA ≤ 60 IU/mL, n = 49), Arm B (partial response, HBV DNA: 60-2000 IU/mL, n = 31) and Arm C (inadequate response, HBV DNA > 2000 IU/mL, n = 20). ADV was added to LAM at week 48 in Arms A and B, but at week 24 in Arm C. Virological response, YMDD mutations, biochemical response, and liver function were evaluated. RESULTS: Comparison of the three arms demonstrated that early complete virologic response at week 24 was associated with maintained viral suppression (undetectable rate of HBV DNA at week 144 was 95.96%, 66.67% and 35.29%, respectively, P = 0.000) and reduced YMDD mutations (mutation rate at week 144 was 0%, 3.23% and 15%, respectively, P = 0.015) after 144 wk treatment. For patients who failed to achieve complete virological response at week 24, switching to combination therapy further decreased HBV DNA level by 1 log10 IU/mL. All three arms obtained biochemical benefits including decline of alanine aminotransferase and elevation of albumin. In patients who developed HBV DNA breakthrough for YMDD mutations, ADV add-on therapy did not induce further multiple drug resistance to LAM or ADV. CONCLUSION: Optimized response-guided add-on therapy of ADV and LAM maintains long-term suppression of HBV DNA and improves liver function in CHB patients with compensated liver cirrhosis.


Subject(s)
Adenine/analogs & derivatives , Antiviral Agents/therapeutic use , Hepatitis B, Chronic/drug therapy , Lamivudine/therapeutic use , Liver Cirrhosis/drug therapy , Organophosphonates/therapeutic use , Adenine/therapeutic use , Adult , Biomarkers/blood , China , DNA, Viral/blood , Drug Resistance, Viral , Drug Therapy, Combination , Female , Genotype , Hepatitis B virus/drug effects , Hepatitis B virus/genetics , Hepatitis B, Chronic/complications , Hepatitis B, Chronic/diagnosis , Humans , Liver Cirrhosis/diagnosis , Liver Cirrhosis/virology , Male , Middle Aged , Mutation , Prospective Studies , Time Factors , Treatment Outcome , Viral Load
4.
Huan Jing Ke Xue ; 34(1): 277-82, 2013 Jan.
Article in Chinese | MEDLINE | ID: mdl-23487951

ABSTRACT

The variation characteristics of the content and components of soil active organic carbon under different fertilizer application were investigated in samples of calcareous fluvo-aquic soil from a field experiment growing winter wheat and summer maize in rotation in the North China Plain. The results showed that RF (recommended fertilization), CF (conventional fertilization) and NPK (mineral fertilizer alone) significantly increased the content of soil dissolved organic carbon and easily oxidized organic carbon by 24.92-38.63 mg x kg(-1) and 0.94-0.58 mg x kg(-1) respectively compared to CK (unfertilized control). The soil dissolved organic carbon content under OM (organic manure) increased greater than those under NPK and single fertilization, soil easily oxidized organic carbon content under OM and NPK increased greater than that under single chemical fertilization. OM and NPK showed no significant role in promoting the soil microbial biomass carbon, but combined application of OM and NPK significantly increased the soil microbial biomass carbon content by 36.06% and 20.69%, respectively. Soil easily oxidized organic carbon, dissolved organic carbon and microbial biomass carbon accounted for 8.41% - 14.83%, 0.47% - 0.70% and 0.89% - 1.20% of the total organic carbon (TOC), respectively. According to the results, the fertilizer application significantly increased the proportion of soil dissolved organic carbon and easily oxidized organic carbon, but there was no significant difference in the increasing extent of dissolved organic carbon. The RF and CF increased the proportion of soil easily oxidized organic carbon greater than OM or NPK, and significantly increased the proportion of microbial biomass carbon. OM or RF had no significant effect on the proportion of microbial biomass carbon. Therefore, in the field experiment, appropriate application of organic manure and chemical fertilizers played an important role for the increase of soil active organic carbon content and the effective control of its key components.


Subject(s)
Carbon/analysis , Fertilizers , Organic Chemicals/analysis , Soil/chemistry , Agriculture/methods , Carbon/chemistry , Manure , Organic Chemicals/chemistry , Soil Microbiology , Triticum/growth & development , Zea mays/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...